Results for tag: "Palmar Fibromatosis Drug"

Palmar fibromatosis is a rare disorder of the hands and fingers characterized by the formation of fibrous nodules on the palmar surface of the hand. It is a type of musculoskeletal disorder, and is treated with drugs that target the underlying cause of the disorder. These drugs are typically used to reduce inflammation, reduce pain, and improve mobility. Commonly used drugs include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. Surgery may also be used to remove the nodules. The Palmar Fibromatosis Drug market is a small but growing market, with a focus on providing effective treatments for this rare disorder. Companies in the market are developing new drugs and therapies to improve the quality of life for those affected by the disorder. Some of the companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more